Alexandra Kropotova
Patrimonio netto: 155 275 $ in data 31/08/2026
Patrimonio netto: 155 275 $ in data 31/08/2026
Dr. Alexandra Kropotova is a Chief Medical Officer & Executive Vice President at SAB Biotherapeutics, Inc. and an Independent Director at iBio, Inc. She is on the Board of Directors at iBio, Inc. Dr. Kropotova was previously employed as a VP-Global Specialty Research & Development by Teva Pharmaceuticals, Inc., a Vice President-Strategy & Head-Strategic Planning by Sanofi, and a Director & Head-Global Clinical Respiratory by Pfizer Inc. She received her MBA from Ohio University Graduate College and a doctorate degree from Pacific State Medical University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 17/09/2026 | 41.853 ( 0,05% ) | 155 275 $ | 31/08/2026 | |
IBIO, INC. -.--% | 01/09/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| IBIO, INC. | Direttore/Membro del Consiglio | 14/10/2020 |
| SAB BIOTHERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 06/06/2022 |
| Società | Posizione | Fine |
|---|---|---|
Teva Pharmaceuticals, Inc.
Teva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | 01/06/2022 |
| SANOFI | Corporate Officer/Principal | 01/01/2016 |
| PFIZER INC. | Direttore/Membro del Consiglio | 01/01/2007 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
iBio, Inc.
iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins | Health Technology |
Ohio University Graduate College
Ohio University Graduate College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SAB Biotherapeutics, Inc.
SAB Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in advancing a new class of immunotherapies | Health Technology |
Teva Pharmaceuticals, Inc.
Teva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale